Daiichi case: Delhi HC allows sale of listed shares of Shivinder Singh

New Delhi: The Delhi High Court has allowed the sale of unencumbered shares held by all respondents, except for Malvinder Singh, in listed companies towards the repayment of an arbitration award by Daiichi Sankyo.

The proceeds are to be deposited with the court registrar, Justice Jayant Nath said on Tuesday.

The chartered accountant is still in the process of valuation of these shares, according to the lawyer for the respondents.

The Delhi Debt Recovery Tribunal has ordered a stay on the sale of unencumbered assets of Malvinder Singh in a separate case by Yes Bank, the lawyers for the respondents told the court. The high court has issued a notice to Yes Bank seeking it’s response.

The respondents on Tuesday moved an application seeking a stay on the enforcement proceedings as a Singapore court has reserved its judgment in an appeal by Malvinder and Shivinder Singh against Daiichi’s award.

Daiichi case: Delhi HC allows sale of listed shares of Shivinder Singh
The counsel for the respondents told court that the judgment was expected in June and the proceedings to enforce the award here should be stayed until then.

The court will take up this application on May 14.

Daiichi Sankyo is seeking to recover over Rs3,500 crore from the Singhs, former promoters of Ranbaxy.

In 2016, a Singapore arbitration tribunal directed the brothers and other respondents like companies controlled by them to pay Daiichi damages for allegedly concealing information regarding wrongdoing at Ranbaxy when selling it to the Japanese drug maker for $4.6 billion in 2008.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    Rajasthan Bans 7 Sub-Standard Medicines

    Rajasthan Bans 7 Sub-Standard Medicines

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23